ClinicalTrials.gg
Sign In

Hodgkin Disease clinical trials

The registry lists 1,383 studies for Hodgkin Disease across more than 10 countries. 163 are recruiting or about to start. 586 of them are mainly about Hodgkin Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 7,164 studies for Hodgkin Disease. How that becomes 1,383 here

This page counts the studies the registry files under Hodgkin Disease, and those it files under no condition that list Hodgkin Diseasethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 7,164Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −71List Hodgkin Disease as a condition, but the registry did not file them under itMost often written as “Classical Hodgkin Lymphoma” (18), “Recurrent/Refractory Childhood Hodgkin Lymphoma” (14), and “Classic Hodgkin Lymphoma” (6). The registry filed them under other conditions only, most often Recurrence (26) and Lymphoma, Large B-Cell, Diffuse (18).
  3. −5,713Match it another way29 name it in the title, 46 in a keyword, and 5,638 by a synonym or other text the search reads.
  4. 1,380Counted here and found by its search79 of them list Hodgkin Disease in their own words; the registry filed them under no condition.
  5. +3
    Counted here, but its search does not find them
  6. 1,383The count on this page

Get an email when these change. Save the Hodgkin Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
804
Terminated
177
Recruiting
135
Status unknown
99
Active, not recruiting
88
Withdrawn
45

Phase

Phase 2
636
Phase 1
447
Phase 3
113
Early Phase 1
13
Phase 4
9

Where

United States
970
Italy
98
Germany
75
France
72
Canada
61
China
56

Who runs them

National Cancer Institute (NCI) (84) · Fred Hutchinson Cancer Center (60) · M.D. Anderson Cancer Center (52) · Memorial Sloan Kettering Cancer Center (48) · City of Hope Medical Center (38) · University of Cologne (30) · St. Jude Children's Research Hospital (27) · Baylor College of Medicine (23)

What is being tested here

Drugs under test in Hodgkin Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Nivolumab12340
Cyclophosphamide96106
Brentuximab Vedotin8667
Pembrolizumab8222
Etoposide5554
Doxorubicin5530
Dacarbazine5626
Fludarabine4177
Vinblastine4530
Tislelizumab405

Drug classes tested here Immune checkpoint inhibitors 29 open · Alkylating agents 18 open · Antimetabolites 12 open · Antibody-drug conjugates (ADCs) 9 open · Antimitotic agents 6 open

Coming up

19phase 3 studies under way
73studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 135 Hodgkin Disease studies recruiting now, 73 (54%) set no upper age limit and 50 (37%) stop at 75 or younger. 46 (34%) take children under 18. 2 (1%) are for women only and 0 (0%) for men only; 9 (7%) take healthy volunteers.

Recruiting studies that take each age, of 135
AgeWomenMen
1030 (22%)30 (22%)
18131 (97%)129 (96%)
30120 (89%)118 (87%)
40113 (84%)112 (83%)
50114 (84%)113 (84%)
65108 (80%)107 (79%)
75101 (75%)100 (74%)
8580 (59%)79 (59%)

Across all 1,383 studies, recruiting or not: 39% stop at 75 or younger and 22% at 65; 34% take children; 1% are for women only and <1% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hodgkin Disease studies take

Of 206 phase 2 interventional studies under Hodgkin Disease, half reached primary completion within 75 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 157 mo41–79 · 91 studies—60 mo41–80 · 66 studies
Phase 1/269 mo53–97 · 63 studies—72 mo59–103 · 48 studies
Phase 275 mo42–111 · 206 studies—80 mo48–115 · 183 studies
Phase 375 mo52–108 · 33 studies—81 mo51–108 · 27 studies
Interventional, no phase43 mo29–128 · 52 studies—43 mo29–128 · 49 studies
Observational61 mo34–149 · 65 studies—63 mo31–149 · 58 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 1,383. Browse all 1,383 → or search them.